Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capecitabine vs 5-FU/LV in Rectal Cancer
NCT03428529Phase 3Completed
- Sponsor
- Instituto Nacional de Câncer José Alencar Gomes da Silva
- Start
- Jan 2011
- Primary completion
- Oct 2016
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
01
Overview
A Phase 3 trial of capecitabine in rectal cancer, sponsored by Instituto Nacional de Câncer José Alencar Gomes da Silva. Started Jan 2011; status: completed.
02
Drugs
capecitabine
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT03428529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03428529.